| Period Ending | Mar 30, 2010 | Mar 30, 2009 | Mar 30, 2008 | Mar 30, 2007 |
|---|
|
Total Revenue
|
270,353,000
|
247,818,000
|
188,379,000
|
165,423,000
| | Cost of Revenue | 199,823,000 | 188,101,000 | 134,160,000 | 123,822,000 | | |
Gross Profit
|
70,530,000
|
59,717,000
|
54,219,000
|
41,600,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative |
-
|
-
|
-
|
-
|
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses | 223,859,000 | 210,351,000 | 151,504,000 | 139,191,000 | | | |
Operating Income or Loss
|
46,494,000
|
37,467,000
|
36,875,000
|
26,232,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 46,494,000 | 37,467,000 | 36,875,000 | 26,232,000 |
|
Interest Expense | (3,824,000) | (2,287,000) | (1,479,000) | (1,201,000) |
|
Income Before Tax |
-
|
-
|
-
|
-
|
|
Income Tax Expense | 15,313,000 | 14,909,000 | 13,412,000 | 5,435,000 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 33,278,000 | 28,264,000 | 27,829,000 | 25,453,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
33,278,000
|
28,264,000
|
27,829,000
|
25,453,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
-
|
-
|
-
|
-
|
|